Linezolid is one of the antibiotics used to treat the Mycobacteroides abscessus infection. However, linezolid-resistance mechanisms of this organism are not well understood. The objective of this study was to identify possible linezolid-resistance determinants in M. abscessus through characterization of step-wise mutants selected from a linezolid-susceptible strain, M61 (minimum inhibitory concentration [MIC]: 0.25 mg/L). Whole-genome sequencing and subsequent PCR verification of the resistant second-step mutant, A2a(1) (MIC: >256 mg/L), revealed three mutations in its genome, two of which were found in the 23S rDNA (g2244t and g2788t) and another one was found in a gene encoding the fatty-acid-CoA ligase FadD32 (c880t -> H294Y). The 23S rRNA is the molecular target of linezolid and mutations in this gene are likely to contribute to resistance. Furthermore, PCR analysis revealed that the c880t mutation in the fadD32 gene first appeared in the first-step mutant, A2 (MIC: 1 mg/L). Complementation of the wild-type M61 with the pMV261 plasmid carrying the mutant fadD32 gene caused the previously sensitive M61 to develop a reduced susceptibility to linezolid (MIC: 1 mg/L). The findings of this study uncovered hitherto undescribed mechanisms of linezolid resistance in M. abscessus that may be useful for the development of novel anti-infective agents against this multidrug-resistant pathogen.
[1]Univ Tunku Abdul Rahman, M Kandiah Fac Med & Hlth Sci, Dr Wu Lien Teh Ctr Res Communicable Dis, Petaling Jaya, Selangor, Malaysia.
[2]Univ Tunku Abdul Rahman, M Kandiah Fac Med & Hlth Sci, Dept Preclin Sci, Petaling Jaya, Selangor, Malaysia.
[3]Univ Tunku Abdul Rahman, M Kandiah Fac Med & Hlth Sci, Dr Wu Lien Teh Ctr Res Communicable Dis, Dept Preclin Sci, Petaling Jaya, Selangor, Malaysia.
(8.0+极速模式)